RUNX2 and thyroid tumor: However, siRNA mediated RUNX2 ablation does not completely abolish the TGF-β effect on CDH6 expression suggesting that other TGF-β–dependent factors beside RUNX2 may be involved in controlling this gene in thyroid tumor cells.